Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. Total Liabilities 2020–2025
Tarsus Pharmaceuticals Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Tarsus Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 218.7M, a 43.47% increase year-over-year.
- Tarsus Pharmaceuticals Inc. total liabilities for 2025 were 218.7M, a 43.47% increase from 2024.
- Tarsus Pharmaceuticals Inc. total liabilities for 2024 were 152.5M, a 122.56% increase from 2023.
- Tarsus Pharmaceuticals Inc. total liabilities for 2023 were 68.5M, a 95.93% increase from 2022.
- Tarsus Pharmaceuticals Inc. total liabilities for 2022 were 35.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Tarsus Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $219 |
| 2024 | $152 |
| 2023 | $69 |
| 2022 | $35 |
| 2021 | $12 |
| 2020 | $6 |
| Tarsus Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $219 |
| 2024-12-31 | $152 |
| 2023-12-31 | $69 |
| 2022-12-31 | $35 |
| 2021-12-31 | $12 |
| 2020-12-31 | $6 |
Tarsus Pharmaceuticals Inc. Total Liabilities — FAQ
Tarsus Pharmaceuticals Inc. (TARS) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TARS's total liabilities history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.